Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideLLYLilly (Eli)
FinDog View：Bullish
TMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | LLY | TMO |
|---|
| Close | 1,137.82 | 648.43 |
| Market Cap | $1.07T | $240B |
| 1M | −3.83% | +10.75% |
| P/E (TTM) | 39.9 | 34.4 |
| Forward P/E | 28.5 | 21.8 |
| P/E 5-Yr Percentile | 6 | 65 |
| P/S | 13.4 | 5.2 |
| P/B | 31.5 | 4.6 |
| Dividend Yield | 0.75% | 0.29% |
| Latest Quarter Revenue | $23.0B | $12.0B |
| Revenue YoY | +47.7% | +10.5% |
| Gross Margin | 85.8% | — |
| Latest Quarter EPS | 7.94 | 4.68 |
| Avg Post-Earnings Move | ±3.5% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.12% | 2.36% |
| 90-Day Net Insider Buying | −$16.0M | −$38.9M |
LLY · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
